Immune checkpoint molecules, including PD-1/PD-L1 and CTLA-4, have been reported to be present in EVs isolated from various cancer types, and these EVPs have been implicated in the regulation of the immune microenvironment and response to immunotherapy. Here, CD274 is linked to cancer.